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Various leptospiral components have been identiﬁed and shown to be involved in tissue
destruction.  In addition, immune responses to leptospires have been implicated in target
organ  damages in severe leptospirosis cases. Several inﬂammatory mediators were  shown
to  be higher in susceptible animals than in resistant hosts. Moreover, cytokines/chemokines
and  serum proteins induced following Leptospira infection were suggested to be biomarkers
for  disease severity in human leptospirosis. This review focuses on the role of immuneeptospirosis
everity
iomarker
responses  in the severity of leptospirosis. Studies in both animal models and humans are
discussed.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDmmune response
ntroduction
eptospirosis is a worldwide zoonosis caused by spirochetes of
enus  Leptospira. Leptospirosis patients present with diverse
linical  manifestations ranging from asymptomatic infec-
ion,  mild infection with fever, headache, myalgia, dyspnea,
o  severe presentations involving multiple organs. Severe
eptospirosis is characterized by jaundice, renal and hepatic
ailure.1–3 In addition, pulmonary hemorrhage has been
ncreasingly shown to be a cause of death of leptospiro-
is patients.4 Although the causative agent of leptospirosis
as  discovered since early 19th century,5 the pathogenetic
echanisms of this infectious disease are still not clearly
nderstood. Several components of pathogenic Leptospira have
een identiﬁed.6–12 However, it is still not known why patients
nfected  with pathogenic Leptospira present with diverse clin-
cal  manifestations.
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Este é um artigo Open Access sob a licençaThe immune response to Leptospira is suggested to play
a  role in organ damages observed in Leptospira infection.
Various inﬂammatory mediators and serum proteins were
thought  to be promising biomarkers for disease severity
prediction. Several studies elicited immune response to lep-
tospira  by stimulating cells with Leptospira or Leptospira
components in vitro or by injecting Leptospira components
into animal models.13–16 Although these experiments could
elicit  an immune response, these approaches may  not mimic
infection-induced of immune response. This review focuses
mainly  on studies of immune response induced by Leptospira
infection. Studies conducted in animal models and in humans
are  reviewed.
To  demonstrate the role of immune response in organicine, Chulalongkorn University, Bangkok 10300, Thailand.
damage observed in infectious diseases, production of inﬂam-
matory  cytokines, chemokines and adhesion molecules are
commonly  investigated. These mediators have also been sug-
gested  to play role in leptospirosis pathogenesis.
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Immune  responses  in  Leptospira  infected
animal models
Hamsters and guinea pigs are commonly used as suscepti-
ble  animal models for leptospirosis. Pathologies and bacterial
burden  in target organs following Leptospira infection were
evaluated  in these susceptible animals. Cytokine gene expres-
sion  in blood from recovered and dead hamsters infected with
leptospires  has been reported.17 TNF-, IL-10, IL-1 and COX-2
expression was  signiﬁcantly higher in dead hamsters than in
the survivors. In addition, the expression of these cytokines
was  also higher in hamsters infected with virulent leptospires
than  in hamsters infected with an avirulent strain.
Mice are known to resist to Leptospira infection. Com-
parison of inﬂammatory mediators in hamsters and Oncins
France  1 (OF1) resistant mice following Leptospira infection
was  reported. Infected hamsters demonstrated pathologies
and  bacterial burden in various organs. OF1 mice showed
rapid  Leptospira clearance. Cytokine/chemokine gene expres-
sion  was  assessed in this study. Compared to resistant mice,
hamsters  showed delayed and massive expression of IL-1, IL-
6, TNF-, cyclo-oxygenase -2, IP-10/CXCL10 and MIP-1/CCL3
in  infected organs. In addition, IL-10, an anti-inﬂammatory
cytokine, was  induced faster in infected resistant mice than
in  infected hamsters.18
Although mice are resistant to Leptospira infection, C3H/HeJ,
the  TLR4 defective mice, have been shown to be susceptible
to  Leptospira infection.19 Immune response induced by lep-
tospires  in resistant (BALB/C) and susceptible (C3H/HeJ) mice
were  compared.20 Expressions of TNF- and MIP-2/CXCL-2
in lungs, kidneys and livers of infected animals were deter-
mined  by qPCR and ELISA. Expressions of TNF- and CXCL-2
were  delayed in C3H/HeJ mice. The sustained MCP-1 and IL-8
expression  in lungs of infected C3H/HeJ was  also shown.
The  alteration of epithelial sodium channel (ENac) and Na-
K-2Cl  (NKCC) co-transporter expression in lungs of hamsters
infected  with Leptospira was  reported. ENac expression was
decreased  whereas the expression of NKCC was  increased in
pulmonary cells of infected hamsters. This study suggested
that  alteration of ion channel following Leptospira infection
may  impair pulmonary function resulting in pulmonary dam-
age  observed in leptospirosis.21
It has been shown in vitro that TNF- decreased ENac and
IL-1  increased Na-K-2Cl co-transporter.22–25 As mentioned ear-
lier,  TNF- and IL-1 were increased in Leptospira infection.
These data suggest that these two cytokines could be involved
in  alteration of ion channels resulting in pulmonary damage.
Expression of TNF-, TGF-, IP-10 and IL-10 in kidneys of
hamsters infected with Leptospira has been reported.26 How-
ever,  correlation of these cytokine expression and kidney
damage  is still not clearly demonstrated.
Immune  responses  in  leptospirosis  patientsVarious studies demonstrated immune responses in human
leptospirosis. Levels of T-cell chemoattractants, IP-10/CXCL10
and  Mig/CXCL9 were  higher in leptospirosis patients than
in  controls.27 However, correlation of these chemokines with 0 1 4;1  8(1):77–81
disease severity was  not shown. The level of IL-8 was  inves-
tigated  in leptospiral hepatitis. IL-8 levels were  signiﬁcantly
higher in leptospirosis patients than in controls and severe
symptoms were  also associated with high IL-8 levels.28
Tajiki and Salomao in 1996 measured plasma level of TNF-
  in 18 leptospirosis patients. They found TNF- level to be
related  to kidney, liver and lung involvement.29 This study
suggested that TNF- level could be a useful marker for poor
prognosis. In addition, the ratio of plasma IL-10/TNF- was
determined in leptospirosis patients with and without organ
involvement. In this study, a high IL-10/TNF- ratio was  asso-
ciated  with less disease severity.30 In contrast, Kyriakidis et al.
in  2011 investigated cytokine levels in 28 leptospirosis patients
and  found a high IL-10/TNF ratio to be associated with fatal
outcome.31
Expression of ICAM-1 (intercellular adhesion molecule-1),
VCAM-1 (vascular cell adhesion molecule-1) and C3a receptor
on  lung tissues of leptospirosis patients was  studied. Expres-
sion  of ICAM-1, VCAM-1 and C3a receptor on alveolar septa of
patients  who died from leptospirosis with pulmonary involve-
ment  was  higher than in control groups.32 The expression
of these adhesion molecules and complement receptor could
promote  leukocyte recruitment to infected tissues.
Levels of other serum proteins such as ST2, long pentraxin-
3  (PTX3) and copeptins have been investigated in leptospirosis
patients. ST2 is a member of interleukin receptor family and
a  receptor for IL-33. Two ST2 isoforms including membrane
(ST2L) and soluble ST2 (sST2) have been identiﬁed. Plasma
ST2  level is increased in heart and inﬂammatory diseases.33–36
PTX3 is an acute phase protein belonging to the pentraxin
family. It is a mediator of inﬂammation and its expression is
induced in various cell types.37 Plasma PTX3 was  shown to be a
severity marker of inﬂammatory conditions and cardiovascu-
lar  diseases.38–41 Copeptin is a 39-amino acid peptide released
from  arginine vasopressin (AVP) during AVP processing. It
has  been suggested to be a biomarker for various conditions
including bacterial sepsis.42–44
Wagenaar et al. determined soluble ST2 (sST2), TNF-, IL-
1,  IL-6, IL-8 and IL-10 levels in 68 severe leptospirosis patients.
This  study suggested that sST2, IL-6 and IL-8 levels were  higher
in  non-survivors than in survivors. In addition, sST2 level was
associated  with bleeding and suggested to be a tissue dam-
age  marker. In another study, IL-6, IL-8 and long pentraxin-3
(PTX3) levels in 52 leptospirosis patients were  investigated.
The  mortality rate of this group of patients was 27%. This study
demonstrated that PTX3, IL-6 and IL-8 levels were  associated
with  disease severity and mortality.45,46
Plasma copeptin level in leptospirosis patients has been
suggested to be a predictor of survival. Among survivors,
copeptin level decreased to baseline level within seven days.47
Serum nitrite has also been shown to be increased in lepto-
spirosis  compared to healthy controls. However, correlation
of  serum nitrite with disease severity was  not shown in this
study.48Discussion
Increasing evidence indicate that immune response could
enhance  tissue damage observed in leptospirosis patients,
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conﬁrm  the reliability of these proteins in disease predic-
tion.  It would be interesting to investigate the levels of
these  suggested biomarkers in larger groups of patients
Leptospira components/toxins
No or mild tissue damage Immune reponses
Early inflammatory mediator production
Rapid anti-inflammatory cytokine production
Rapid bacterial clearance
No or mild tissue pathologies
Tissue damage
Immune responses
Delayed and sustained inflammatory mediator production
High levels of inflammatory mediators
Delayed anti-inflammatory cytokine production
Persistence or delay of bacteria clearance
Severe tissue pathologies
Leptospira components/toxins
A
B
Fig. 1 – Diagrams suggesting how inﬂammatory responses
involve  in different disease outcomes of leptospirosis. (A)
Leptospira  infection in resistant animal models or in hosts
with  mild symptoms. Leptospira components or toxins
could  directly induce tissue damage. Infected hosts
recognize Leptospira and respond aiming at eradicating
these infectious agents. Inﬂammatory responses occur
early  and rapidly to eradicate organisms. Further tissue
dissemination is prevented. Anti-inﬂammatory cytokines
are  produced to regulate inﬂammation. Finally, leptospires
are  eradicated and no or mild tissue damage is observed.
(B)  Leptospira infection in susceptible animal models or in
hosts  with severe symptoms. Leptospira components or
toxins  could directly induce tissue damage. There is no
clear  evidence demonstrating that different pathogenic
Leptospira contain different virulence factors. Infected hosts
recognize  Leptospira and respond aiming at eradicating
these infectious agents. However, in these hosts,
inﬂammatory responses were  delayed. Organisms persist
and  promote further inﬂammatory responses. The delay of
Leptospira eradication may  provide time for bacterial
dissemination to various organs. These prolonged andb r a z j i n f e c t d i
specially in severe cases. As described above, both inﬂam-
atory  and anti-inﬂammatory cytokines were  induced by
eptospira  infection. Moreover, chemokines participating in
eutrophil and mononuclear cell recruitment were also pro-
uced.
TNF-  is a cytokine widely studied in immune-
ediated diseases and is the most investigated cytokine
n  leptospirosis.20,31,49 It is an inﬂammatory cytokine pro-
uced following toll-like receptor (TLR) stimulation.50 C3H/HeJ
ice  are TLR-4 defective and were shown to be suscepti-
le  to Leptospira infection.19 However, correlation of TLR-4
utation and leptospirosis pathogenesis is not clearly
stablished.
Compared to infected BALB/C mice, TNF- production in
eptospira  infected C3H/HeJ mice was  delayed in one study.21
imilar result was  observed when TNF- gene expression was
nvestigated  in mice and hamsters infected with Leptospira.
xperiment in C57BL/6 mice with knockout TNF- receptors
TNFR) has been reported. Severe renal inﬂammation was
bserved  in convalescent TNFR deﬁcient mice. This study sup-
orted  the role of rapid induction of TNF- following Leptospira
nfection.51 In addition, TNF- induction was  shown to be
igher  in hamsters that did not die after experimental lep-
ospiral  infection.17
These data suggest that for bacterial eradication, inﬂam-
atory  cytokines should be induced rapidly. Delayed expres-
ion  may  allow for bacterial colonization and multiplication.
owever, production of inﬂammatory cytokines should be
roperly  regulated. Prolonged production could promote fur-
her tissue damage. Leptospira toxins could directly induce
issue  damage which is further promoted by inﬂammatory
esponse.
High IL-10/TNF- ratio was  shown to be associated
ith less disease severity in one study.30 However, in
nother study, high IL-10/TNF- ratio was  associated with
atal  outcome of leptospirosis patients.31 These data sug-
ested  the role of both inﬂammatory and anti-inﬂammatory
ytokines in disease outcomes of leptospirosis. However,
pplication of these two cytokines ratio as a disease
arker needs to be further investigated in larger groups of
atients.
IL-10  level was  induced faster in infected BALB/C than
n  infected hamsters.18 The rapid production of this anti-
nﬂammatory cytokine could regulate inﬂammatory cytokines
roduction  resulting in alleviation of tissue damage. Besides
romoting  inﬂammation, TNF- could be involved in impair-
ent  of pulmonary function by altering epithelium sodium
hannel.21,22 Role of TNF- in sodium channel change in lepto-
pirosis  with pulmonary hemorrhage has not been directly
eported.
Chemokine involvement has been widely investigated
n leptospirosis. Induction of IL-8 was  delayed and sus-
ained  in C3H/HeJ mice infected with leptospires than in
he  resistant mice.52 The association of IL-8 level and dis-
ase  severity and mortality has been shown in leptospirosis
atients.28In addition to cytokines and chemokines, other serum
nﬂammatory mediators including sST2, PTX3 and copeptin
ere  investigated whether they could be used as biomarkers
or  leptospirosis severity. 1 4;1  8(1):77–81  79
Conclusion
Fig. 1A and B are diagrams suggesting how host inﬂamma-
tory  responses participate in a wide range of leptospirosis
symptoms. Various studies have shown that cytokines and
serum  proteins are promising biomarkers for leptospiro-
sis  severity. However, further studies should be done tomassive  immune response could promote further tissue
damages  resulting in severe organ damage observed in
susceptible  animals or hosts with severe clinical
manifestations.
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with different degrees of leptospirosis illnesses. In addition,
detection of inﬂammatory mediators should be performed
using  samples collected at various times after infection.
The  data obtained could conﬁrm whether rapid or delayed
production of inﬂammatory/anti-inﬂammatory mediators
inﬂuences disease outcomes. Moreover, most studies inves-
tigated  cytokines/chemokines levels in patient sera. In
order  to demonstrate whether immune responses partic-
ipate  in organ damage in leptospirosis, investigation of
cytokines/chemokines levels in target organs should provide
more  convincing evidence.
Genetic difference could play an important role in a wide
range  of clinical manifestations in leptospirosis patients. Mice
with TLR4 defective are susceptible to infection.19 Although,
there  are increasing numbers of reports on Leptospira genes,
there  are a few studies on human genetics involving severe
Leptospira infection. Single nucleotide polymorphisms in IL-4
and IL-4 receptor that had higher frequencies in leptospiro-
sis  patients were  reported.53 However, it has been shown that
IL-4  deﬁciency had no effect on resistance of BALB/C mice to
Leptospira  infection.51
Finally, the number of leptospires that infect each patient
and  the virulence of the infecting leptospires could play a role
in  different outcomes following Leptospira infection. However,
currently,  there is no report correlating leptospiral load and
leptospirosis  disease severity. In addition, disease outcomes
in  patients infected with pathogenic Leptospira with different
degrees  of virulence have not been compared.
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